Paper Review Records
全部论文审稿周期
19 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
318
天
Circulating and tumor microenvironment immunomarkers associate with immunotherapy efficacy in advanced bladder urothelial carcinoma: an exploratory multicenter study integrating genomic and immunophenotypic profiling
作者
Sha Liu; Junjun Lu; Zhaojie Lyu; Zhengmao Lu; Yunmei Liu; Ruiying Zhang; Wentao Xu; Guoping Sun; Yingying Du; Lei Huang展开收起
作者单位
1. The First Affiliated Hospital of Anhui Medical University; 2. Peking University Shenzhen Hospital; 3. The First Affiliated Hospital of Naval Medical University; 4. Shanghai University; 5. Guangzhou University of Chinese Medicine; 6. Anhui Medical University; 7. The First Affiliated Hospital of Naval Medical University/Changhai Hospital, Naval Medical University展开收起
155
天
53
天
Real-world utilization of immune checkpoint inhibitors in medicare-eligible patients with triple-negative breast cancer in the United States
作者
Xiaohan Hu; Amin Haiderali; Yezhou Sun; Wilbur Pan展开收起
作者单位
1. Value & Implementation Outcomes Research Oncology; 2. BARDS RWE Capabilities and Analytics; 3. Global Clinical Development展开收起
145
天
Cost-effectiveness analysis of penpulimab plus anlotinib versus sorafenib as first-line therapy for advanced hepatocellular carcinoma
作者
Zhiwei Zheng; Lisheng Huang; Yuling Zhang; Huide Zhu; Ling Fang展开收起
作者单位
1. Cancer Hospital of Shantou University Medical College; 2. Shantou University Medical College展开收起
82
天
182
天
FAQ
Immunotherapy审稿要多久?
截至2026-11-19,CrushSCI 收录了 Immunotherapy 的 19 篇完整审稿记录。最快一篇从收稿到录用用了 43 天(Safety and tolerability of a new intravenous immunoglobulin 10% in patients with primary immunodeficiency,2026-06-04 收稿,2026-07-17 录用),最慢一篇用了 318 天;平均 145.2 天,中位数 137 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
